Download full report with analyst certification and important disclosures
Dec 23 2021, 07:10 GMT
Uniphar
Three deals driving mid-single-digit upgrades
- Sectors : Pharma and healthcare
- Companies : Uniphar
DAVY VIEW
Uniphar has been busy again on M&A, adding three bolt-ons for an estimated total consideration of €70-75m (including deferreds). Each transaction is expected to generate a ROCE >15% within three years and will be initially ‘mid-single-digit’ earnings accretive on a pro-forma basis. Uniphar has now executed on 12 transactions since IPO in 2019, in each instance adding new strategic capability and furthering its leadership ambitions in each division. We expect more of the same in 2022.
